2021
DOI: 10.1111/cas.14907
|View full text |Cite
|
Sign up to set email alerts
|

Enhanced antitumor activity of combined lipid bubble ultrasound and anticancer drugs in gynecological cervical cancers

Abstract: This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 12 publications
(6 citation statements)
references
References 55 publications
0
6
0
Order By: Relevance
“…This delivery system could be applied to nanomedicine such as DOXIL. Our collaborators reported anti-tumor effects in various types of tumors in mice 27,60) (Fig. 3C) or dog.…”
Section: Blood-tumor Barrier Openingmentioning
confidence: 88%
See 3 more Smart Citations
“…This delivery system could be applied to nanomedicine such as DOXIL. Our collaborators reported anti-tumor effects in various types of tumors in mice 27,60) (Fig. 3C) or dog.…”
Section: Blood-tumor Barrier Openingmentioning
confidence: 88%
“…3B) in mouse xenograft model with lipid-stabilized microbubbles and diagnostic ultrasound scanner. 27) This bubble and ultrasound-mediated drug delivery system (BUS-DDS) significantly enhanced anti-tumor effects without any adverse events. Furthermore, Hirabayashi et al developed anti-epidermal growth factor receptor (EGFR) antibody-conjugated microbubbles (EGFR-MB).…”
Section: Blood-tumor Barrier Openingmentioning
confidence: 97%
See 2 more Smart Citations
“…Colon cancer was also treated using UTMD technology with anti-PD-1, and the number and effector function of CD8 + T cells were systemically increased, thereby augmenting anti-PD-1 efficacy [ 118 ]. For gynaecologic tumours, UTMD combined with bevacizumab or plasmid pCMV-IL-12 or anti-PD-L1 antibody enhanced efficacy in cervical, endometrial, and ovarian cancers by increasing the migration and infiltration of CD8 + T cells [ 52 , 119 , 120 ]. In addition, UTMD has also been studied for the therapy of malignant melanoma.…”
Section: Enhanced Antitumor Efficacy In Different Cancer Species With...mentioning
confidence: 99%